Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991;41(2):171-4.
doi: 10.1007/BF00265912.

Pharmacokinetics of intravenous bisoprolol in obese and non-obese volunteers

Affiliations

Pharmacokinetics of intravenous bisoprolol in obese and non-obese volunteers

C Le Jeunne et al. Eur J Clin Pharmacol. 1991.

Abstract

The pharmacokinetics of a single i.v. dose of dl-bisoprolol 0.16 mg.kg-1 ideal body weight has been studied in 8 obese women (mean weight 91 kg; 161% of ideal body weight) and 8 non-obese women (51 kg; 94% of ideal body weight). Compared to the controls, the obese subjects showed an increase in the total apparent volume of distribution (Vz) (182 vs 1351) and a decrease in Vz per kg body weight (2 vs 2.71.kg-1). There was a negative correlation between Vz l.kg-1 and the percentage of ideal body weight (r = -0.672). Total body clearance was increased, but t1/2 and renal clearance was unchanged. It is concluded that tissue diffusion of bisoprolol in obese subjects is limited, despite its lipophilicity, possibly because of alteration in the blood flow to adipose tissue produced by bisoprolol.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Chromatogr. 1988 Apr 29;426(2):431-7 - PubMed
    1. J Cardiovasc Pharmacol. 1986;8 Suppl 11:S58-60 - PubMed
    1. J Pharmacol Exp Ther. 1981 Jun;217(3):681-5 - PubMed
    1. Clin Pharmacokinet. 1986 May-Jun;11(3):199-213 - PubMed
    1. J Pharm Pharmacol. 1981 Mar;33(3):172-3 - PubMed

LinkOut - more resources